A revolutionary wearable patch has been created to detect early signs of the deadliest form of skin cancer. Developed by American researchers, this wireless device enables patients to conduct self-screening at home, potentially leading to early detection of melanoma and reducing the need for unnecessary biopsies.
Skin cancer, particularly melanoma, is highlighted as one of the most life-threatening types of cancer. According to Melanoma UK, more than 19,000 individuals in the UK are estimated to be diagnosed with melanoma by 2025. Early detection plays a critical role in successful treatment, but current methods heavily rely on visual examination, which can be subjective and miss crucial early warning signals.
To address these challenges, a team at Wake Forest University School of Medicine in North Carolina designed a battery-free, flexible patch that directly measures the electrical properties of skin lesions in a simple and non-invasive manner. By analyzing bioimpedance, which indicates the ease of electrical signals passing through living tissue, the patch can identify abnormal areas that may necessitate further medical attention.
The patch, which operates wirelessly with a small reader device, was tested on 10 volunteers by applying it to both pigmented skin lesions, like moles, and adjacent healthy skin. Through safe electrical signals and statistical analysis, significant differences between healthy and abnormal skin were confirmed. The study, published in Biomedical Innovations, illustrated the patch’s ability to clearly differentiate between healthy skin and potentially concerning spots.
Notably, the patch can detect unique electrical signals from suspicious moles or lesions irrespective of skin tone. Dr. Mohammad Moghimi, the lead researcher, emphasized the importance of early detection in treating skin cancer effectively and the patch’s potential to enable easier monitoring of suspicious skin lesions by patients and primary care providers.
Unlike traditional visual inspection methods, this innovative patch does not require batteries or chips, making it lightweight, disposable, and cost-effective. It provides objective, numerical data about skin health, reducing the need for unnecessary biopsies and aiding doctors in making well-informed decisions.
With the ability to offer additional information on lesions and support other diagnostic techniques, the patch is considered effective across all skin tones and capable of identifying changes in small or visually unclear lesions. The research team aims to enhance the patch further by incorporating conductive hydrogel electrodes for improved performance and comfort.
Future plans involve conducting larger clinical studies to assess the patch’s real-world effectiveness and its ability to differentiate between benign and malignant lesions. Dr. Moghimi envisions making early skin cancer detection accessible to everyone by providing a user-friendly tool that can be utilized at home or in primary care settings, aiming to reduce missed or delayed diagnoses and enhance patient outcomes.